The metabolism and pharmacokinetics of acrylamide: Implications for mechanisms of toxicity and human risk estimation

Drug Metabolism Reviews

Volumn 28, Issue 4, 1996, Pages 527-590

  Calleman, Carl Johan ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRYLAMIDE;

ANIMAL EXPERIMENT; CARCINOGENICITY; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; DRUG UPTAKE; HUMAN; MOUSE; MUTAGENICITY; NEUROTOXICITY; NONHUMAN; PHARMACOKINETICS; RAT; REVIEW; RISK FACTOR;

EID: 0029903973     PISSN: 03602532     EISSN: None     Source Type: Journal    
DOI: 10.3109/03602539608994018     Document Type: Review

References (111)

1. Abou-Donia, M. B., Ibrahim, S. M., Corcoran, J. J., Lack, L., Friedman, M. A., and Lapadula, D. M. (1993). Neurotoxicity of glycidamide, an acrylamide metabolite, following intraperitoneal injections in rat. J. Toxicol. Environ. Health, 39, 447-464.
2. Adler, I.-D. (1990). Clastogenic effects of acrylamide in different germ-cell stages of male mice. Banbury Rep. 34: Biology of Mammalian Germ Cell Mutagensis. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
3. Agrawal, A. K., Seth, P. K., Squibb, R. E., Tilson, H. A., Uphouse, L. L., and Bondy, S. C. (1981). Neurotransmitter receptors in brain regions of acrylamide-treated rats. I. Effects of a single exposure to acrylamide. Pharmacol. Biochem. Behav., 14, 527-531.
4. American Cyanamid Co. (1989). Final report: A life-time oncogenicity study in rats with acrylamide, Study No. 85033. Wayne, NJ, June 27.
5. Bachmann, M., Myers, J. E., and Bezuidenhout, S. S. (1992). Acrylamide monomer and peripheral neuropathy in chemical workers, Am. J. Ind. Med., 21, 217-222.
6. Backer, L. C., Dearfield, K. L., Erexson, G. L., Campbell, J. A., Westbrook-Collins, B., and Allen, J. W. (1989). The effect of acrylamide on mouse germ-line and somatic cell chromosomes. Environ. Mol. Mutagen., 13, 218-226.
7. Bailey, E., Farmer, P. B., Bird, I., Lamb, J. H., and Peal, J. A. (1986). Monitoring exposure to acrylamide by the determination of S-(2-carboxyethyl)cysteine in hydrolyzed hemoglobin by gas chromatographymass spectrometry. Anal. Biochem., 157, 241-248.
8. Banerjee, S., and Segal, A. (1986). In vitro transformation of C3H/10T1/ 2 and NIH/3T3 cells by acrylonitrile and acrylamide. Cancer Lett., 32, 293-304.
9. Barfknecht, T. R., Mecca, D. J., and Naismith, R. W. (1988). The genotoxic activity of acrylamide. Environ. Mol. Mutagen., 11(Suppl. 11), Abstract 18.
10. Beiswager, C. M., Mandella, R. D., Graessle, T. R. Reuhl, K. R., and Lowndes, H. E. (1993). Synergistic neurotoxic effects of styrene oxide and acrylamide: Glutathione-independent necrosis of cerebellar granule cells, Toxicol. Appl. Pharmacol, 118, 233-244.
11. Beranek, D. T., Weis, C. C., and Swenson, D. H. (1980). A comprehensive quantitative analysis of methylated and ethylated DNA using high pressure liquid chromatography, Carcinogenesis, 7, 595-606.
12. Bergmark, E. (1992). Hemoglobin dosimetry and comparative toxicity of acrylamide and its metabolite glycidamide. Thesis, University of Stockholm.
13. Bergmark, E., Calleman, C. J., and Costa, L. G. (1991). Formation of hemoglobin adducts of acrylamide and its epoxide metabolite glycidamide in the rat. Toxicol. Appl. Pharmacol., 111, 352-363.
14. Bergmark, E., Calleman, C. J., He, F., and Costa, L. G. (1993). Determination of hemoglobin adducts in humans occupationally exposed to acrylamide. Toxicol. Appl. Pharmacol., 120, 45-54.
15. Brat, D. J., and Brimijoin, S. (1993). Acrylamide and glycidamide impair neurite outgrowth in differentiating N1E.115 neuroblastoma without disturbing rapid bidirectional transport of organellas observed by video microscopy. J. Neurochem., 60, 2145-2152.
16. Brismar, T., Hildebrand, C., and Tegner, R. (1987). Nodes of Ranvier in acrylamide neuropathy: Voltage clamp and electron microscopic analysis of rat sciatic nerve fibres at proximal levels. Brain Res., 423, 135-143.
17. Broxup, B., Robinson, K., Losos, G., and Beyroudy, P. (1989). Correlations between behavioral and pathological changes in the evaluation of neurotoxicity. Toxicol. Appl. Pharmacol., 101, 510-520.
18. Bull, R. J., Robinson, M., and Stober, J. (1984a). Carcinogenic activity of acrylamide in the skin and lung of Swiss-ICR mice. Cancer Lett., 24, 209-212.
19. Bull, R. J., Robinson, M., Laurie, R. D., Stoner, G. D., Greisiger, E., Meier, J. R., and Stober, J. (1984b). Carcinogenic effects of acrylamide in SENCAR and A/J mice. Cancer Res., 44, 107-111.
20. Butterworth, B. E., Eldridge, S. R., Sprankle, C. S., Working, P. K., Bentley, K. S., and Hurtt, M. E. (1992). Tissue-specific genotoxic effects of acrylamide and acrylonitrile. Environ. Mol. Mutagen., 20, 148-155.
21. Calleman, C. J. (1982). In vivo dosimetry by means of alkylated hemoglobin - a tool in the design of tests for genotoxic effects. Banbury Rep. 13: Indicators of Genotoxic Exposures, pp. 157-168.
22. Calleman, C. J. (1984). Hemoglobin as a dose monitor and its application to the risk estimation of ethylene oxide. Thesis, University of Stockholm.
23. Calleman, C. J., Bergmark, E., and Costa, L. G. (1990). Acrylamide is metabolized to glycidamide in the rat: Evidence from hemoglobin adduct formation. Chem. Res. Toxicol., 3, 406-412.
24. Calleman, C. J., Stern, L. G., Bergmark, E., and Costa, L. G. (1992). Linear versus nonlinear models for hemoglobin adduct formation by acrylamide and its metabolite glycidamide: Implications for risk estimation. Cancer Epidemiol. Biomarkers Prev., 1, 361-368.
25. Calleman, C. J., Bergmark, E., Stern, L. G., and Costa, L. G. (1993). A nonlinear dosimetric model for hemoglobin adduct formation by the neurotoxic agent acrylamide and its genotoxic metabolite glycidamide. Env. Health Perspect., 99, 221-223.
26. Calleman, C. J., Wu, Y., He, F., Tian, G., Bergmark, E., Zhang, S., Deng, H., Wang, Y., Crofton, K. M., Fennell, T., and Costa, L. G. (1994). Relationships between biomarkers of exposure and neurological effects in a group of workers exposed to acrylamide. Toxicol. Appl. Pharmacol., 126, 361-367.
27. Calleman, C. J., He, F., Bergmark, E., and Costa, L. G. (1996). Determination of hemoglobin adducts as a tool for neurological risk estimation of human exposure to acrylamide. Manuscript.
28. Carlson, G. P., Fossa, A. A., Morse, M. A., and Weaver, P. M. (1986). Binding and distribution studies in the SENCAR mouse of compounds demonstrating a route-dependent tumorigenic effect. Env. Health Perspect., 68, 53-60.
29. 14C-acrylamide to macromolecules in SENCAR and BALB/c mice following oral and topical administration. Toxicol. Appl. Pharmacol., 79, 307-313.
30. 14C]acrylamide to proteins in the mouse nervous system. Neurochem. Int., 18, 191-197.
31. Collins, J. J., Swaen, G. M. H., Marsh, G. M., Utidjian, H. M. D., Caporossi, J. C., and Lucas, L. J. (1989). Mortality patterns among workers exposed to acrylamide. J. Occup. Med., 7, 614-617.
32. Costa, L. G., Deng, H., Gregotti, C., Manzo, L., Faustman, E. M., Bergmark, E., and Calleman, C. J. (1992). Comparative studies on the neuro- and reproductive toxicity of acrylamide and its epoxide metabolite glycidamide in the rat. Neurotoxicology, 13, 219-224.
33. Costa, L. G., Deng, H., Calleman, C. J., and Bergmark, E. (1995). Evaluation of the neurotoxicity of glycidamide, an epoxide metabolite of acrylamide: Behavioral, neurochemical and morphological studies. Toxicology, 98, 151-161.
34. Dearfield, K. L., Abernathy, C. O., Ottley, M. S., Brantner, J. H., and Hayes, P. (1988). Acrylamide: Its metabolism, developmental and reproductive effects, genotoxicity, and carcinogenicity. Mutat. Res., 195, 45-77.
35. Deng, H., He, F., Zhang, S., Calleman, C. J., and Costa, L. G. (1993). Quantitative measurements of vibration thresholds in healthy adults and acrylamide workers. Int. Arch. Occup. Emir. Health, 65, 53-56.
36. el-Din, A. Y., al-Maskati, H. A., Mohamed, D. Y., and Dairi, M. G. (1993). Acrylamide as an inducer of metabolic activation system (S9) in rats. Mutat. Res., 300, 91-97.
37. Dixit, R., Mukhtar, H., Seth, P. K., and Murti, C. R. K. (1981). Conjugation of acrylamide with glutathione catalyzed by glutathione-S-transferase of rat liver and brain. Biochem. Pharmacol., 30, 1739-1744.
38. Edwards, P. M. (1975a). The distribution and metabolism of acrylamide and its neurotoxic analogues in rats. Biochem. Pharmacol., 4, 1277-1282.
39. Edwards, P. M. (1975b). Neurotoxicity of acrylamide and its analogues and effects of these analogues and other agents on acrylamide neuropathy. Br. J. Ind. Med., 32, 31-38.
40. Ehrenberg, L. (1974). Genetic toxicity of environmental chemicals. Acta Biol. Iugosl., Ser. F, Genetika, 6, 367-398.
41. EPA: Environmental Protection Agency (1987). Final draft for drinking water criteria document on acrylamide. Office of Drinking Water, USEPA, Washington, DC.
42. EPA: Environmental Protection Agency (1990). Assessment of health risks from exposure to acrylamide. Office of Toxic Substances, USEPA, Washington, DC.
43. EPA: Environmental Protection Agency (1992). Integrated risk information system, acrylamide. Revised 01/01/92.
44. Farmer, P. B., Bailey, E., Naylor, S., Anderson, D., Brooks, A., Cushmir, J., Lamb, J. H., Sepai, O., and Tang, Y.-S. (1993). Identification of endogenous electrophiles by means of mass spectrometric determination of protein and DNA adducts. Env. Health Perspect., 99, 19-24.
45. Frantz, S. W., Dryzga, N. L., Freshour, N. L., and Watanabe, P. G. (1985). In vivo/in vitro determination of cutaneous penetration of residual monomer from polyacrylamides. Toxicologist, 5, Abstract 39.
46. Gibaldi, M., and Perrier, D. (1982). Pharmacokinetics. Marcel Dekker, New York, pp. 272-277.
47. Gutierrez-Espeleia, G. A., Hughes, L. A., Piegorsch, W. W., Shelby, M. D., and Generoso, W. M. (1992). Acrylamide: Dermal exposure produces genetic damage in male mouse germ cells. Fundam. Appl. Toxicol., 18, 189-192.
48. Hashimoto, K., and Aldridge, W. N. (1970). Biochemical studies on acrylamide, a neurotoxic agent. Biochem. Pharmacol., 19, 2591-2604.
49. Hashimoto, K., Sakamoto, J., and Tanii, H. (1981). Neurotoxicity of acrylamide and related compounds and their effects on male gonads in mice. Arch. Toxicol., 47, 179-189.
50. Hashimoto, K., and Tanii, H. (1985). Mutagenicity of acrylamide and its analogues in Salmonella typhimurium. Mutat. Res., 158, 129-133.
51. Hashimoto, K., Hayashi, M., Tanii, H. and Sakamoto, J. (1988). Toxicological aspect of acrylamide neuropathy. J. UOEH, 10, Suppl., 209-218.
52. Hattis, D., and Shapiro, K. (1990). Analysis of dose/time/response relationships for chronic toxic effects: The case of acrylamide. Neurotoxicology, 11, 219-236.
53. He, F., Zhang, S., Wang, H., Li, G., Zhang, Z., Li, F., Dong, X., and Hu, F. (1989). Neurological and electroneuromyographic assessment of the adverse effects of acrylamide on occupationally exposed workers. Scand. J. Work Environ. Health, 15, 125-129.
54. Howland, R. D., Ypas, I. L., and Lowndes, H. E. (1980). The etiology of acrylamide neuropathy: Possible involvement of neuron specific enolase, Brain Res., 190, 529-535.
55. IARC (1986). IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, No. 39, Some Chemicals Used in Plastics and Elastomers. IARC, Lyon, pp. 41-66.
56. 14C]acrylamide in beagle dogs and miniature pigs. Food Chem. Toxicol., 25, 871-875.
57. Jakubowski, M., Linhart, I., Pielas, G., and Kopecky, J. (1987). 2-Cyanoethylmercapturic acid (CEMA) in the urine as a possible indicator of exposure to acrylonitrile. Br. J. Ind. Med., 44, 834-840.
58. Johnson, K. S., Gorzinski, S., Bodner, R., Campbell, R., Wolf, C., Friedman, M., and Mast, R. (1986). Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol. Appl. Pharmacol., 85, 154-168.
59. Kaplan, M. L., Murphy, S. D., and Gilles, F. H. (1973). Modification of acrylamide neuropathy in rats by selected factors. Toxicol. Appl. Pharmacol., 85, 154-168.
60. Kedderis, G. L., and Batra, R. (1993). Species differences in the hydrolysis of 2-cyanoethylene oxide, the epoxide metabolite of acrylonitrile. Carcinogenesis, 14, 685-689.
61. King, D. J., and Noss, R. R. (1989). Toxicity of polyacrylamide and acrylamide monomer. Rev. Environ. Health, 8, 3-15.
62. Knaap, A. G. A. C., Kramers, P. G. N., Voogd, C. E., Bergkamp, W. G. M., Groot, M. G., Langebroek, P. G., Mout, H. C. A., van der Stel, J. J., and Verharen, H. W. (1988). Mutagenic activity of acrylamide in eukaryotic systems but not in bacteria. Mutagenesis, 3, 263-268.
63. Kotlovsky, Yu., Grishanova, A., and Ivanov, V. V. (1984). Effect of methylmethacrylate and acrylamide on the system of microsomal oxidation in rat liver tissue. Vopr. Med. Khim., 30, 44-47.
64. Lijinsky, W., and Andrews, A. W. (1980). Mutagenicity of vinyl compounds in Salmonella typhimurium. Teratogen. Carcinogen. Mutagen., 1, 259-267.
65. 14C]acrylamide in male and pregnant Swiss-Webster mice studied by whole-body autoradiography. Toxicol. Appl. Pharmacol., 86, 457-465.
66. Matsuoka, M., Igisu, H., Lin, J., and Inoue, N. (1990). Effects of acrylamide and N,N'-methylene-bis-acrylamide on creatine kinase activity, Brain Res., 507, 351-353.
67. Miller, M. J., Carter, D. E., and Sipes, I. G. (1982). Pharmacokinetics of acrylamide in Fisher-344 rats. Toxicol. Appl. Pharmacol., 63, 36-44.
68. Miller, M. J., and McQueen, C. (1986). The effect of acrylamide on hepatocellular DNA repair. Environ. Mutagen., 8, 99-108.
69. Miller, M. S., and Spencer, P. S. (1985). The mechanism of acrylamide axonopathy. Ann. Rev. Pharmacol. Toxicol., 25, 643-666.
70. Moore, M. M., Amtower, A., Doerr, C., Brock, K. H., and Dearfield, K. L. (1987). Mutagenicity and clastogenicity of acrylamide in L5178Y mouse lymphoma cells. Environ. Mutagen., 9, 261-267.
71. Myers, J. E., and Macun, I. (1991). Acrylamide neuropathy in a South African factory: An epidemiological investigation. Am. J. Ind. Med., 19, 487-493.
72. Neuhäuser-Klaus, A., and Schmahl, W. (1989). Mutagenic and teratogenic effects of acrylamide in the mammalian spot test. Mutat. Res., 226, 157-162.
73. NIOSH: National Institute of Occupational Safety and Health (1991). NIOH and NIOSH Basis for an Occupational Health Standard. Acrylamide: A Review of the Literature. DHHS (NIOSH) Publication No. 91-115, Cincinnati, OH.
74. Okajiwa, Y., and Maloney, F. P. (1989). Overwork weakness in rats with acrylamide neuropathy. Am. J. Phys. Med. Rehabil., 68, 66-69.
75. Ortiz, E., Patel, J. M., and Leibman, K. C. (1981). Specific inactivation of aniline hydroxylase by a reactive intermediate formed during acrylamide biotransformation by rat liver microsomes. Adv. Exp. Med. Biol., 136, 1221-1227.
76. O'Shaugnessy D. J., and Losos, G. J. (1986). Comparison of central and peripheral nervous system lesions caused by high-dose short-term and low-dose subchronic acrylamide treatment in rats. Toxicol. Pathol., 14, 389-394.
77. Osterman-Golkar, S., Ehrenberg, L., Segerbäck, D., and Hällström, I. (1976). Evaluation of genetic risks of alkylating agents. II. Haemoglobin as a dose monitor. Mutat. Res., 34, 1-10.
78. Osterman-Golkar, S., Farmer, P. B., Segerbäck, D., Bailey, E., Calleman, C. J., Svenson, K., and Ehrenberg, L. (1983). Dosimetry of ethylene oxide in the rat by quantitation of alkylated histidine in hemoglobin. Teratogen. Carcinogen. Mutagen., 3, 395-405.
79. Osterman-Golkar, S., MacNeela, J. P., Turner, M. J., Walker, V., Swenberg, J. A., Sumner, S. J., Youtsey, N., and Fennel, T. R. (1994). Monitoring of exposure to acrylonitrile using adducts with N-terminal valine in hemoglobin. Carcinogenesis, 15, 2701-2707.
80. Pastoor, T., Heydens, W., and Richardson, R. J. (1980). Time- and dose-related excretion of acrylamide metabolites in the urine of Fisher-344 rats. Toxicol. Lett., S. I. No. 1, p. 215.
81. Pastoor, T., and Richardson, R. J. (1981). Blood dynamics of acrylamide in rats. Toxicologist, 1, 53.
82. Ramsey, J. C., Young, J. D., and Gorzinski, S. J. (1984). Acrylamide: Toxicodynamics in rats. Unpublished report, Dow Chemical Company, Midland, MI.
83. Raymer, J. H., Sparacino, C. M., Velez, G. R., Padilla, S., MacPhail, R. C., and Crofton, K. M. (1993). Analysis of acrylamide in rat serum and sciatic nerve by gas chromatography/electron capture detection of the derivative, 2-bromopropenamide. J. Chromatogr. Biomed. Appl., 619, 223-234.
84. Russell, L. B., Hunsicker, P. R., Cacheiro, N. L. A., and Generoso, W. M. (1991). Induction of specific-locus mutations in male germ cells of the mouse by acrylamide monomer. Mutat. Res., 262, 101-107.
85. Sabri, M. I. (1983). In vitro and in vivo inhibition of glycolytic enzymes by acrylamide. Neurochem. Pathol., 1, 179-191.
86. Sabri, M. I. (1990). Acrylamide impairs fast and slow axonal transport in rat optic system. Neurochem. Res., 15, 603-608.
87. Sakamoto, J., and Hashimoto, K. (1986). Reproductive toxicity of acrylamide and related compounds in mice-effects on fertility and sperm morphology. Arch Toxicol., 59, 201-205.
88. Schoental, R., and Cavanagh, J. B. (1977). Mechanisms involved in the "dying-back" process - an hypothesis implicating coenzymes. Neuropathol. Appl. Neurobiol., 3, 145-157.
89. Sega, G. A., Valdivia Alcota, R. P., Tancongco, C. P., and Brimer, P. (1989). Acrylamide binding to the DNA and protamine of spermiogenic stages in the mouse and its relationship to genetic damage. Mutat. Res., 216, 221-230.
90. Sega, G. A., Generoso, E. E., and Brimer, P. A. (1990). Acrylamide exposure induces a delayed unscheduled DNA synthesis in germ cells of male mice that is correlated with the temporal pattern of adduct formation in testis DNA. Environ. Mol. Mutagen., 16, 137-142.
91. Segerbäck, D. (1983). Alkylation of DNA and hemoglobin in the mouse following exposure to ethene and ethene oxide. Chem.-Biol. Interact., 45, 139-151.
92. 14C]acrylamide. Carcinogenesis, 16, 1161-1165.
93. Shelby, M. D., Cain, K. T., Hughes, L. A., Braden, P. W., and Generoso, W. M. (1986). Dominant lethal effects of acrylamide in male mice. Mutat. Res., 173, 273-278.
94. Shelby, M. D., Cain, K. T., Cornett, C. V., and Generoso, W. M. (1987). Acrylamide: Induction of heritable translocations in male mice. Environ. Mutagen., 9, 363-368.
95. Shiraishi, T. (1978). Chromosome aberrations induced by monomeric acrylamide in bone marrow and germ cells of mice. Mutat. Res., 57, 313-324.
96. Smith, E. A., and Oehme, F. W. (1991). Acrylamide and polyacrylamide: A review of production, use, environmental fate and neurotoxicity. Rev. Env. Health, 9, 215-228.
97. Smith, M. K., Zenick, H., Preston, R. J., George, E. L., and Long, R. E. (1986). Dominant lethal effects of subchronic acrylamide administration in the male Long-Evans rat. Mutat. Res., 173, 273-277.
98. Snellings, W. M., Weil, C. S., and Maronpot, R. R. (1984). A two-year inhalation study of the carcinogenic potential of ethylene oxide in Fischer 344 rats. Toxicol. Appl. Pharmacol., 75, 105-117.
99. Sobel, W., Bond, G. G., Parsons, T. W., and Brenner F. E. (1986). Acrylamide cohort mortality study, Br. J. Ind. Med., 43, 785-788.
100. Solomon, J. J., Fedyk, J., Mukai, F., and Segal, A. (1985). Direct alkylation of 2′-deoxynucleosides and DNA following in vitro reaction with acrylamide. Cancer Res., 45, 3465-3470.
101. Srivastava, S. P., Seth, P. K., Das, M., and Mukhtar, H. (1985). Effects of mixed-function oxidase modifiers on neurotoxicity of acrylamide in rats. Biochem. Pharmacol., 34, 1099-1102.
102. 13C nuclear magnetic resonance spectroscopy. Chem. Res. Toxicol., 5, 81-89.
103. Svensson, K., and Osterman-Golkar, S. (1984). Kinetics of metabolism of propene and covalent binding to macromolecules in the mouse. Toxicol. Appl. Pharmacol., 73, 363-372.
104. Tilson, H. A. (1981). The neurotoxicity of acrylamide: An overview. Neurobehav. Toxicol. Teratol., 3, 445-461.
105. Tripathy, N. K., Patnaik, K. K., and Nabi, Md. J. (1991). Acrylamide is genotoxic to the somatic and germ cells of Drosophila melanogaster. Mutat Res., 259, 21-27.
106. Tsuda, H., Shimizu, C. S., Taketomi, M. K., Hasegawa, M. M., Hamada, A., Kawata, K. M., and Inui, N. (1993). Acrylamide: Induction of DNA damage, chromosomal aberrations and cell transformation without gene mutations. Mutagenesis, 8, 23-29.
107. Voogd, C. E., van der Stel, J. J., and Jacobs, J. J. J. A. A. (1981). The mutagenic action of aliphatic epoxides. Mutat. Res., 89, 269-282.
108. Walum, E., Odland, L., Romert, L., Ekblad-Sekund, G., Nilsson, M., Calleman, C. J., Bergmark, E., and Costa, L. G. (1992). Biochemical approaches to neurotoxicology in vitro: Attempts to develop a test system for chemically induced axonopathy. In Proc. Conf. In Vitro Toxicology: An Alternative to Animal Testing. Academic Press, London.
109. Warr, T. J., Parry, J. H., Callander, R. D., and Ashby, J. (1990). Methylvinyl sulphone: A new class of Michael-type genotoxin. Mutat. Res., 245, 191-199.
110. WHO (1985). Environmental Health Criteria No. 49, Acrylamide. Geneva.
111. Working, P. K., Bentley, K. S., Hurtt, M., and Mohr, K. L. (1987). Comparison of the dominant lethal effects of acrylonitrile and acrylamide in male Fischer 344 rats. Mutagenesis, 2, 215-220.